Thrombocytopenia in hepatitis C infection and chronic liver disease

Experimental and Clinical Hepatology

Volumn 5, Issue 3-4, 2009, Pages 15-19

  Pluta, Andrzej ^a   Gutkowski, Krzysztof ^b   Sawka, Dariusz ^c  

^a BASILDON HOSPITAL   (United Kingdom)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Oncology District Hospital in Brzozów   (Poland)

Author keywords

Hronic liver disease; Thrombocytopenia; Thrombopoietin receptor agonists

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; ELTROMBOPAG; IMMUNOGLOBULIN; PREDNISOLONE; STEROID; THROMBOCYTE ANTIBODY; THROMBOPOIETIN RECEPTOR;

AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIVIRAL THERAPY; ARTIFICIAL EMBOLISM; BLEEDING TIME; BONE MARROW EXAMINATION; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; HEPATITIS C; HUMAN; HYPERSPLENISM; IMMUNE MEDIATED THROMBOCYTOPENIA; LAPAROSCOPIC SURGERY; LEUKOPENIA; LIVER FUNCTION TEST; MEGAKARYOPOIESIS; PARTIAL SPLENIC EMBOLIZATION; PORTAL HYPERTENSION; PROTEIN BLOOD LEVEL; REVIEW; SPLENECTOMY; SPLENOMEGALY; SPLENORENAL SHUNT; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE LIFESPAN; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REPLICATION;

EID: 77950827981     PISSN: 17343038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Goulis , Chau TN, Jordan S et al: Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut, 1999; 44: 764-768 (Pubitemid 29195930)
2. Nagamine T, Ohtuka T, Takehra K et al: Thrombocytopenia associated with hepatitis C infection. J Hepatol, 1996; 24: 135-140
3. Klipstein FA, Linderbaum J: Folate deficiency in chronic liver disease. Blood, 1965; 25: 443-456
4. Levine RF, Spivak JI, Meagher RC et al: Effect of ethanol on thrombopoiesis. Br J Haematol, 1986; 62: 345-354
5. Hugenholtz GC, Porte RJ, Lisman T: The Platelet and Platelet Function Testing in Liver Disease. Clin Livr Dis, 2009; 13: 11-20
6. Adinolfi L, Giodano M, Andreana A et al: Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenias in patients with chronic viral hepatitis. Br J Hematol, 2001; 113: 590-595 (Pubitemid 32524375)
7. Martin T, Somberg K, Meng G et al: Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med, 1997; 127: 285-288 (Pubitemid 27352049)
8. th ed. Lippincort Williams & Wilkins 2006, Philadelphia Sect B. Acquired Hemorrhagic Disorders, 1025-1033
9. Rajan SK, Espina BM, Liebman HA: Hepatitis C virus related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombcytopenic purpura. Br J Haematol, 2005; 129: 818-824
10. Koyke Y, Yoneyama A, Shirai J et al: Evaluation of thrombopoietic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentration. Thromb Hemost, 1998; 79: 1106-1110 (Pubitemid 28297155)
11. Panasiuk A, Prokopowicz D, Zak J et al: Reticulated platelets as a marker of megacaryocytopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration. Hepatogastroenterology, 2004; 51: 1124-1128 (Pubitemid 38822483)
12. Cines DB, Liebman H, Stasf R: Pathobioloy of Secondary Immune Thrombocytopenia. Semin Hematol, 2009; 46,1(Suppl.2): S2-14
13. Peck-Radasovlievic M, Wichlas M, Pudlich J et al: Blunted thrombopoietin response to interferon alfa induced thrombocytopenia during treatment for hepatitis C. Hepatology, 1998; 28: 1424-1429 (Pubitemid 28493856)
14. Kuter D: Clinical applications of thrombopoietic growth factors: Up To Date, 2009; 17: 1-25
15. McHutchinson JG, Dusheiko G, Shiffman MI et al: Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med, 2007; 357: 2227-2236 (Pubitemid 350190753)
16. Pockros PJ, Duchini A, McMillan R et al: Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol, 2002; 97: 2040-2045
17. Garcia-Suarez J, Burgaleta C, Hernands N et al: Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenter, 2002; 97: 2042-2045
18. Sukuraya M, Murakami H, Uchiumi H et al: Steroid refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection. Eur J Haematol, 2002; 68: 49-53 (Pubitemid 34407542)
19. Sukuraya M, Murakami H, Uchiumi H et al: Steroid refractory chronic thrombocytopenic purpura associated with hepatitis C infection. Eur J Haematol, 2002; 68: 49-53 (Pubitemid 34407542)
20. PereiraJ, Accatino L, Alfaro J et al: Platelet autoantibodies in patients with chronic liver diseases. Am J Hematol, 1995; 50: 173-178
21. Kajihara M, Kato S, Okazaki Y et al: A role of autoantibody-mediated platelet destruction in throbocytopenia in patients with cirrhosis. Hepatology, 2003; 37: 1267-1276 (Pubitemid 36667305)
22. Ramos-Casas M, Garcia-Carrasco M, Lopez-Medrano F et al: Severe autoimmune cytopenias in treatment naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore), 2003; 82: 87-96 (Pubitemid 36331640)
23. Rajan S, Liebman HA: Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am J Hematol, 2001; 68: 202-209 (Pubitemid 32983211)
24. Medeiros BC, Seligmn PA, Everson GT, Forman LM: Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2 plus ribavirin treatment for hepatitis. J Clin Gastroenteol, 2004; 38: 84-86
25. Arimura K, Arima N, Ohtsubo H et al: Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia. Acta Hematol, 2004; 112: 217-218 (Pubitemid 39541269)
26. McHutchinson JG, Dusheiko G, Shiffman MI et al: Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med, 2007; 357: 2227-2236 (Pubitemid 350190753)
27. Busel JB, Cheng G, Saleh MN et al: Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Eng J Med, 2007; 357: 2237-2247 (Pubitemid 350190754)
28. Sharara AI, Rockey DC: Gastroesophageal variceal haemorrhage. N Engl J Med, 2001; 34522: 669-681
29. Kercher K, Carbonell A, Neniford B et al: Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg, 2004; 8: 120-126 (Pubitemid 38117286)
30. Aoki R: Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" Thrombocytopenia. J Clin Invest, 1966; 45: 645-657
31. Schmidt K, Rasmussen J, Bekker C et al: Kinetics and in vitro distribution of indium-III labeled autologous platelets in chronic hepatic disease: mechanism of thrombocytopenia. Scand J Gastroeterol, 1985; 34: 39-46
32. Hashizume M, Tomikawa M, Akahoshi T et al: Laparoscopic splenectomy for portal hypertension, Hepatogastroenterol, 2002; 49: 847-852
33. Kercher KW, Carbnell AM, Henifors BT et al: Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastroentest Surg, 2004; 8: 120-126
34. Nio M, Hayashi Y, Sano N et al: Long-term efficacy of partial splenic embolization I children. J Peditr Surg, 2003; 38: 1760-1762 (Pubitemid 37505406)
35. Shilyansky J, Roberts EA, Superina RA: Distal splenorenal shunts for the treatment of severe thrombocytopenia from portal hypertension in children. J Gastrointest Surg, 1999; 3: 167-172
36. Hayashi H, Beppu T, Masuda T et al: Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients J Gastroentrol Hepatol, 2007; 22: 1638-1642
37. Lee CM, Leung TK, Wang HJ et al: Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol, 2007; 13: 619-622 (Pubitemid 46210932)
38. Argo C, Galogun RA: Blood Products, Volume Control, and Renal Support in the Coagulopathy of Liver Disease. Clin Liver Dis, 2009; 3: 73-85
39. Turittoo VT, Weiss HJ: Red blood cells their dual role in thrombus formation. Science, 1980; 207: 541-543
40. Hathcock JJ: Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol, 2006; 26: 1729-1737
41. Kajihara M, Okazaki Y, Kalo S et al: Evaluation of platelets kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol, 2007; 22: 112-118
42. Giannini EG, Savarino V: Thrombocytopenia in liver disease. Curr Opin Hematol, 2008; 15: 473-480